The document discusses stages of drug discovery including compound sources, filtering, screening, target identification, validation, and lead identification and optimization. It describes principles of drug design such as designing new molecules, understanding structure-activity relationships, and analyzing absorption, distribution, metabolism, and excretion. Drug design approaches include knowing properties that make a molecule a drug and receptor, and designing drugs to fit receptors. Types of drug design discussed are theoretical using quantitative structure-activity relationships and structure-based techniques like docking, X-ray crystallography, and homology modeling.
DRUG DISCOVERY
Drug Discovery without a lead
LEAD DISCOVERY/IDENTIFICATION
LEAD MODIFICATION
CONCEPT OF PRODRUGS AND SOFT DRUGS
DRUG RECEPTOR INTERACTIONS
Lead Optimization is an important technique in new drug development. It encompasses several fields such as synthetic chemistry, phytochemistry, analysis, pharmacology and microbiology.
DRUG DISCOVERY
Drug Discovery without a lead
LEAD DISCOVERY/IDENTIFICATION
LEAD MODIFICATION
CONCEPT OF PRODRUGS AND SOFT DRUGS
DRUG RECEPTOR INTERACTIONS
Lead Optimization is an important technique in new drug development. It encompasses several fields such as synthetic chemistry, phytochemistry, analysis, pharmacology and microbiology.
Introduction of QSAR, Steps involved in QSAR, Hansch Analysis, Free Wilson Analysis, Mixed Approach method, Advantage,Disadvantage and Application of QSAR.
SAR versus QSAR, History and development of QSAR, Types of physicochemical
parameters, experimental and theoretical approaches for the determination of
physicochemical parameters such as Partition coefficient, Hammet’s substituent
constant and Taft’s steric constant. Hansch analysis, Free Wilson analysis, 3D-QSAR
approaches like COMFA and COMSIA.
The techniques of drug designing and in silico studies are well defines in this presentation. Mooreover, the various softwares which are used in new era for determining the drug targets inside the body are elaborated.
Introduction of QSAR, Steps involved in QSAR, Hansch Analysis, Free Wilson Analysis, Mixed Approach method, Advantage,Disadvantage and Application of QSAR.
SAR versus QSAR, History and development of QSAR, Types of physicochemical
parameters, experimental and theoretical approaches for the determination of
physicochemical parameters such as Partition coefficient, Hammet’s substituent
constant and Taft’s steric constant. Hansch analysis, Free Wilson analysis, 3D-QSAR
approaches like COMFA and COMSIA.
The techniques of drug designing and in silico studies are well defines in this presentation. Mooreover, the various softwares which are used in new era for determining the drug targets inside the body are elaborated.
Computer Added Drug Design is one of the latest technology of medicine world. This short slide will help you to know a little about CADD.If you want to know a vast plz go throw the reference book.
Drug design is a multidisciplinary field that involves the discovery and development of new medications. It combines principles from chemistry, biology, and pharmacology to create compounds with specific therapeutic effects. The goal is to design drugs that interact with biological targets, such as proteins or enzymes, to modulate their activity and treat diseases. Modern drug design often utilizes computational methods, structural biology, and high-throughput screening to identify potential drug candidates efficiently.
Point:-
• Introduction to drug design
• Objective of drug design
• Types & Approaches of drug design
• Introduction to drug Discovery
• Limitation of drug design
• Introduction to QSAR
• Parameter of QSAR
• Introduction to CAD
• Pharmacophore
• Docking
• Docking Analysis
• Combinatorial chemistry
• High Throughput Screening
• Drug from Natural sources
Sushant khatal
Khatal sushant
Drug design project or Domin in b Pharmacy so it's helpful to b Pharmacy students
B. PHARM 6TH SEMESTER DRUG DESIGN. FACTORS, QSAR, DRUG DISCOVERY, DRUG DEVELOPMENT, VARIOUS APPROACHES FOR DRUG DESIGN, PARTITION COEFFICIENT, HAMMETS EQUATION, TAFTS STERIC PARAMETER, HANSCH ANALYSIS
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
2. STAGES OF DRUG DISCOVERY:
• COMPOUND SOURCES → FIITERING →COMBINATIONAL
LIBRARIES → SCREENING → TARGET IDENTIFICATION
→TARGET VALIDATION→SCREENING AND PROFILING→
LEAD IDENTIFICATION → LEAD OPTIMIZATION
DRUG DESIGN:
• Drug design or rational drug design or simply rational design, is the
"inventive process of finding new medications based on the knowledge of a
biological target."
• Drug design involves the design of small molecules that are complementary
in shape and charge to the bio-molecular target with which they interact and
therefore will bind to it.
Ways of Drug Designing:
• Development of ligands with desired properties for the targets having
known structure and function.
• Development of ligands with pre-defined properties for the targets whose
structural information may be or may not be known.
3. PRINCIPLES OF DRUG DESIGN
• :The basic principle of the medicinal chemistry is to design the new chemical
entities (NCEs) and their optimization and development as useful drug molecule
for the treatment of the disease.
This can be done by determining the:
• Design of new molecules. ü How the interact with biological macromolecules such
as proteins and nucleic acids.
• The relationship between their chemical structure & biological activities.
• Conduction of structure activity analysis.
• Their ADME throughout the body.
DRUG DESIGN APPROACHES:
• Drug design may be divided into two phases. Elementary concepts about drugs,
receptors and drug-receptor interactions are applied to human diseases.
• •1st phase
• Comprises the essential building blocks of drug design
• 2nd phase
• To connect a drug-receptor interaction to human disease
4. • 1ST PHASE:This phase is further divided into three steps.
• Step 1:Involves knowing what property turn a molecule into drug. All drugs may be
molecules but all molecules are not certainly drugs. Drug molecules are “small”
molecules (molecular weight usually below 800g per mol. Often below 500).e.g.
Penicillin, acetylsalicylic acid and morphine are all small organic molecules.
• STEP II:Involves knowing what properties turn a macromolecule into a receptor.
All receptors may be macromolecules, but all macromolecules are certainly not
receptors .Receptor macromolecules are frequently proteins or glycoproteins.
• STEP III:Involves knowing how to design and synthesize a drug to fit into a
receptor. This prototype compound is referred to as lead compound.
• 2ND PHASE:Once the basics of drug design is obtained, the drug designer next
focuses upon the task of connecting a drug-receptor interaction to human disease.
This is the goal of the second phase. This phase requires an understanding of
biochemistry and of the molecular pathology of the disease being treated
6. Theoretical aspects of drug design
• This is the non experimental study of drug design. Structure
activity relationship (SAR) and quantitative structure activity
relationship (QSAR) collectivity known as Q(SAR) are the
theoretical models that can be used to predict the
physiochemical, biological and environmental fate properties
of molecules.
• The quantitative aspects of the biological activity and the
mathematical relationships existing be-tween the biological
activity (BA), chemical structure (C) and physicochemical
properties (P) must be under-stood for the drug design.
• Aim of these models is to develop correlations between
biological or pharmacological activity and physiochemical
properties of a set of molecules.
7. .
• SAR usually involve the interpretation of activity in terms of the
structural features of the drug molecule.
8. TECHNIQUES OF STRUCTURE BASED
DRUG DESIGN
• There are various techniques of structure based drug design like:
• QSAR
• Docking
• X-ray crystallography
• NMR
• Homology modeling
3..QSAR:(Quantitative structure activity relationships)
QSAR is a mathematical relationship between a biological activity and physico-chemical
properties of drug. A general formula for the QSAR can be given by the following:
Biological activity= f (Physico-chemical properties)
So, it can be used to evaluate the activity of new compounds.
Mathematical models are built based on structural parameters to describe.
Earlier 2D-QSAR, but 3D-QSAR have been adopted.
3D-QSAR methodologies are CoMFA, CoMSIA and HQSAR
9. DOCKING:
• “Docking is the method which predicts the preferred orientation of one molecule to a second
when bound to each other to form a stable complex.”
• Molecular docking is one of the most frequently used method in structure based drug
designing due to its ability to predict the binding confirmation of small molecule ligands to
the appropriate target binding site. Docking can be achieved through two interrelated steps:
1st by sampling confirmation of the ligand in the active site of the protein; 2nd then ranking
these confirmations via a scoring function.
10. Applications of docking:
• Hit identification • Lead optimization • Bioremediation
Uses of Docking:
• Drug target • Protein ligand interaction • Protein therapies • Engineered protein enzymes
• Better understand the machinery of life
Enzyme-inhibitor class
Antibody-antigen class
• For predicting both the strength and type of produced signal
X-ray Crystallography:
X-ray crystallography is a technique used for identifying the atomic and molecular structure of a
crystal, in which the crystalline atoms cause a beam of incident X-rays to diffract into many
specific directions.
By measuring the angles and intensities of these diffracted beams, a crystallographer can produce a
three dimensional picture of the density of electrons within a crystal. From this electron density, we
can determined:
a) Position of atoms within a crystal b) Chemical bonds
c) Disorder d) and various other informations
11. NMR:
• A variety of nuclear magnetic resonance applications have been have been developed for
structure-based drug discovery. NMR provides many advantages over other methods, such as
the ability to directly observe chemical compounds and target biomolecules and to be used for
ligand-based and protein-based approaches.
Homology modeling:
• A common challenge in CADD research is determining the 3D structure of proteins because
the 3D structure for only a small fraction of the protein is known.
• Bioinformatics software tools are then used to predict the 3D structure of the target based on
the known 3D structure of the templates.
• Quantitative structure activity relationship
• This non experimental part of drug design comprising study of both structure-activity
relationship studies activity-property relationship studies
Biological activ-ity of a drug depends on the types and magnitude of interactions between the
receptor and the drug molecule'. Various structural attributes of the drug molecule like electronic
distribution, steric feature, etc., are the deter-mining factors regulating the interactions. All
Quantita-tive Structure-Activity Relationship (QSAR) studies are based on the notion that BA is
function of C and/or P.
BA=
BA= f (C, P)
• C, P)
12. • Goals of QSAR
The goals of QSAR studies include
• better understanding of the mode of action
• Prediction of new analogs with better activity
• Optimization of the lead compound to reduce toxicity and increase selectivity
Steps involved in QSAR studies
The QSAR methodology enables the development of mathematical models.
—
It can be used to predict the biological activity of newly designed compounds.
—
There are three steps involved in this procedure:
1. Creation of a database in which calculation of various physiochemical and structural
parameters of congeneric take place.
2. Regression analysis leading to model development between biological activities versus derived
physiochemical descriptors.
3. Validation of the models and prediction of the biological activity of the designed compounds.
13. • Statistical methods used in QSAR analysis:
—
Statistical methods are an essential component of QSAR work.
—
They help to build models.
—
Estimate models predictive abilities.
—
Validate an already existing model.
—
Find the relationships and co relationship among the variables and the activities.
—
Data analysis methods are used to recombine data into forms and groups and
observations into hierarchies
Model Development Procedures:
2D QSAR Analysis:
The 2D descriptors are usually developed by using the atoms and
connective information of the molecules.
In 2D QSAR physicochemical parameters such as hydrophobic, steric, hydrogen
acceptor, hydrogen donor, electronic field effect or resonance are used.
In addition to these parameters de novo constants or indicator variables with to 0
to 1 value denoting the absence or presence of certain features are also used.
14. • 3D QSAR analysis:
• 3D QSAR are quantitative models that relate the biological activity of
small molecules with their properties calculated in 3D space.
• Hence 3D properties of a molecule are considered rather than that of
individual substituents.
• The 3D structures are usually generated from 2D OR 2D with
configurational information or 3D structure database.
• Among all the 3D QSAR techniques, CoMFA is the most widely used and
has shown unprecedented accuracy in prediction.
• Some of these approaches to QSAR are based on the statistical analysis of
the 3D interaction fields.
• These are generated by measuring over a regular 3D grid the interaction
energy between a small probe atom or a group and the ligands.
15. 4.Computer aided drug design
Computational Chemistry Overview:
Computational chemistry method is the use of theory and computer technology to
calculate molecular properties.
The greatest potential power of computational chemistry is the domain of making
predictions prior to experimental work.
It solves chemical problems and calculates the structure and properties of
compounds.
In general computational chemistry refers to energy based methods
Approaches of Computational Chemistry:
Computational chemistry approaches can be divided into two broad categories:
1. Quantum Mechanics Based
2. Classical Mechanics Based
Approach that gives result in shortest possible time is used.
1. Quantum Mechanics Based
It covers the area of Ab initio ( high volume data processing applications)
Density functional theory
16. 2. Classical Mechanics Based
It refers to force field (molecular mechanics)calculations .
Molecular dynamics simulations.
Computer Aided Drug Design (CADD):
Computer aided drug design is an encompassing term. It includes
•Energy based calculations
•QSAR
•Data base searching
•Pharmacophore perception methods
Structure Based Methods
Structure based methods are principle analogues to HTS in that both target and ligand
structure information is imperative. Structure based approaches include:
•Ligand docking
•Pharmacophore
•Ligand design Methods
17. Ligand Based Methods
• Ligand based methods use inly ligand information for predicting activity
depending on its similarity / dissimilarity to previously known active ligands.
The method has advantage of requiring minimal compound design or prior
knowledge and technologies.
Force Field Methods
• In past force field methods were known as Westhimer Method. Calculations
of force field method depend on fundamental concept that a ball and spring
model may be used to approximate a molecule
It represents computational methods and resources that are used
to facilitate the design and discovery of new therapeutics. CADD
is an exciting and diverse discipline in which various aspects of
applied and basic research merge. Molecular mechanics and
dynamics are used to predict the confirmation of small
molecules.
18. • Applications of CADD:
• Elimination of compounds with undesirable effects.
• Identify and optimize new drugs.